Neoprobe participating at investor conferences

Neoprobe (AMEX:NEOP) CEO Dr. Mark Pykett will be participating at three investor conferences, including Deutsche Bank’s Annual Med Tools Investor Forum in Boston today and tomorrow, Oppenheimer’s Annual Healthcare Conference in New York on Dec. 13-14 and the 2012 Biotech Showcase in San Francisco on Jan. 9-11.

Dr. Pykett’s presentations will provide investors with a general business update regarding development activities currently underway as well as an overview of the company’s growth strategy as it repositions itself as a precision diagnostics company focused on radiopharmaceuticals.

A live webcast of presentations made at Oppenheimer and the Biotech Showcase conferences will be accessible through the Investors section of the company’s website at http://www.neoprobe.com. Following each conference, the webcast will be archived for approximately 30 days.